Fidelity Investments
VRNA

Fidelity Investments’s Verona Pharma VRNA Stock Holding History

Fidelity Investments’s Portfolio VRNA Stock Details VRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-312,386
Closed -$29.5M – 5593
2025
Q2 		$29.5M Buy
312,386
+107,394
+52% +$7.95M ﹤0.01% 1570
2025
Q1 		$13M Sell
204,992
-90,996
-31% -$5.44M ﹤0.01% 1826
2024
Q4 		$13.7M Sell
295,988
-420,600
-59% -$15.8M ﹤0.01% 1849
2024
Q3 		$20.6M Sell
716,588
-3,103
-0.4% -$76.4K ﹤0.01% 1695
2024
Q2 		$10.4M Sell
719,691
-1,011,662
-58% -$14.8M ﹤0.01% 1858
2024
Q1 		$27.9M Sell
1,731,353
-3,171,024
-65% -$54.8M ﹤0.01% 1544
2023
Q4 		$97.5M Sell
4,902,377
-2,055,581
-30% -$30.4M 0.01% 1024
2023
Q3 		$113M Sell
6,957,958
-151,812
-2% -$2.92M 0.01% 916
2023
Q2 		$150M Buy
7,109,770
+2,542,591
+56% +$54.2M 0.01% 835
2023
Q1 		$91.7M Buy
4,567,179
+2,393,033
+110% +$51.7M 0.01% 1012
2022
Q4 		$56.8M Buy
2,174,146
+1,760,746
+426% +$23.4M 0.01% 1209
2022
Q3 		$4.22M Buy
+413,400
New +$3.48M ﹤0.01% 2222

Other funds holding VRNA

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelity Investments's VRNA Position: Q3 2025 in Review

Fidelity Investments sold out of Verona Pharma (VRNA) in Q3 2025, closing a stake of 312,386 shares — an estimated $29.5M sold.

Fidelity Investments first reported a position in VRNA in Q3 2022 and held it in 12 quarters. The position peaked at $150M in Q2 2023. 243 funds tracked by Wall St. Rank hold VRNA as of Q3 2025.

  • Fidelity Investments reported no remaining Verona Pharma position as of Q3 2025 after selling out during the quarter.
  • Fidelity Investments sold 312,386 Verona Pharma shares in Q3 2025, an estimated $29.5M.
  • Fidelity Investments first reported a position in Verona Pharma in Q3 2022 and held it in 12 quarters.
  • Fidelity Investments's Verona Pharma position peaked at $150M in Q2 2023.
  • 243 funds tracked by Wall St. Rank held Verona Pharma as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.